407
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States

, , ORCID Icon, &
Pages 213-226 | Received 10 Nov 2022, Accepted 15 Mar 2023, Published online: 29 Mar 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.